MRK Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
16.6B
+2.0%
16.3B
-0.7%
16.4B
-5.1%
17.3B
+9.3%
15.8B
Cost of Revenue
4.4B
+4.8%
4.2B
-24.4%
5.6B
+44.0%
3.9B
+8.4%
3.6B
Gross Profit
12.2B
+1.0%
12.1B
+11.4%
10.8B
-19.2%
13.4B
+9.6%
12.2B
Operating Expenses
12.8B
-17.4%
15.5B
+121.3%
7.0B
+1.2%
6.9B
-4.7%
7.3B
R&D
9.7B
-22.6%
12.6B
+224.0%
3.9B
-8.2%
4.2B
+4.6%
4.0B
SG&A
2.9B
+7.6%
2.7B
-6.8%
2.9B
+10.1%
2.6B
-0.6%
2.6B
Operating Income
-584000000
+82.8%
-3396000000
-188.2%
3.9B
-40.8%
6.5B
+30.3%
5.0B
EBITDA
1.1B
+168.1%
-1689000000
-125.9%
6.5B
-15.3%
7.7B
+15.5%
6.7B
Net Income
-1337000000
+68.5%
-4243000000
-243.2%
3.0B
-48.8%
5.8B
+30.7%
4.4B
EPS (Basic)
$-0.54
+68.6%
$-1.72
-244.5%
$1.19
-48.7%
$2.32
+31.8%
$1.76
EPS (Diluted)
$-0.54
+68.6%
$-1.72
-244.5%
$1.19
-48.7%
$2.32
+31.8%
$1.76
Shares (Diluted)
2.5B
-0.1%
2.5B
-0.6%
2.5B
-0.5%
2.5B
-0.6%
2.5B
Merck & (MRK) โ€” Financials